Disclosures for "Association Between Mean Platelet Volume and Functional Outcome in Patients with Acute Ischemic Stroke: A Systematic Review with Meta-Analysis")
-
Miss Pascual-Guevara has nothing to disclose.
-
Mr. Cabanillas Lazo has nothing to disclose.
-
Miss Cruzalegui Bazán has nothing to disclose.
-
Mr. Vicuña has nothing to disclose.
-
Miss Cierto Torre has nothing to disclose.
-
Mr. Vallejos has nothing to disclose.
-
Dr. Sequeiros Chirinos has nothing to disclose.
-
Carlos Alva-Diaz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Farma. Carlos Alva-Diaz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Farma. The institution of Carlos Alva-Diaz has received research support from Roche farma.